Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)

NCT00093262 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT00093262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00093262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)
Lead sponsor
The Medicines Company
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2003
Completion date
October 31, 2004
Enrollment
206 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension